Date: 2016-01-08
Type of information: Establishment of a new subsidiary in the EU
Compound:
Company: Innoviva previously known as Theravance (USA - CA)
Therapeutic area: Allergic diseases - Inflammatory diseases - Respiratory diseases
Type agreement: name change
Action mechanism:
Disease:
Details: * On January 8, 2016, Theravance, a healthcare-focused asset management company, announced that it changed its name to Innoviva , effective January 7, 2016 . In addition to Innoviva\'s new name, the company has also unveiled a new corporate identity and website, available at www.inva.com. The name change comes a year and a half after Theravance, Inc. spun-off and separated from Theravance Biopharma, Inc., a pharmaceutical research and development company.
Financial terms:
Latest news: